Why is Orchid Pharma falling/rising?

As of 22-Sep, Orchid Pharma Ltd's stock price is currently at Rs 766.70, reflecting a decline of Rs 21.85 or 2.77%. The stock has underperformed its sector today by 1.69% and has experienced a trend reversal after three consecutive days of gains, touching an intraday low of Rs 753.65, which is a drop of 4.43%. Over the past week, the stock has shown a positive return of 8.05%, but it has underperformed over the last month with a slight decline of 0.69%. The company has high institutional holdings at 20.82%, which may indicate some confidence among larger investors, but it also faces significant challenges, including weak long-term fundamental strength with a low return on equity (ROE) of 4.68% and a concerning EBIT to interest ratio of 1.99. The company has reported negative results for the last three consecutive quarters, with a notable decline in operating profit of 19.64%, contributing to the stock's downward movement.
Broader market context shows that while the Sensex has gained 0.46% over the past week, Orchid Pharma's performance has been significantly weaker in the long term, with a year-to-date decline of 57.81% compared to the Sensex's gain of 5.15%. The stock's performance over the last year has also been poor, with a return of -45.13%, which is substantially worse than the broader market's decline of only 2.82%. This stark contrast highlights the challenges faced by Orchid Pharma in a market that has generally been more favorable, further contributing to the stock's current downward trajectory.